• Citer

PSMA-targeted PET imaging in patients with metastatic triple-negative breast cancer: results of the prospective PRISMA trial.

par Manley, Martin;Nader-Marta, Guilherme;Ozturk, Ayça Arcay;Kassas, Mutaz ;Rothé, Françoise ;Taraji, Loubna;Sotiriou, Christos ;Wimana, Zéna;Salgado, Roberto;Flamenne, Patrick;Gebhart, Géraldine
Référence European journal of nuclear medicine and molecular imaging
Publication Publié, 2025-11

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	PSMA-targeted PET imaging in patients with metastatic triple-negative breast cancer: results of the prospective PRISMA trial.
Auteur:	Manley, Martin; Nader-Marta, Guilherme; Ozturk, Ayça Arcay; Kassas, Mutaz; Rothé, Françoise; Taraji, Loubna; Sotiriou, Christos; Wimana, Zéna; Salgado, Roberto; Flamenne, Patrick; Gebhart, Géraldine
Informations sur la publication:	European journal of nuclear medicine and molecular imaging
Statut de publication:	Publié, 2025-11
Sujet CREF:	Sciences bio-médicales et agricoles
Mots-clés:	FDG PET/CT
	PSMA PET/CT
	Triple-negative breast cancer
MeSH keywords:	Humans
	Middle Aged
	Glutamate Carboxypeptidase II -- metabolism
	Positron Emission Tomography Computed Tomography -- methods
	Triple Negative Breast Neoplasms -- diagnostic imaging -- pathology -- metabolism
	Female
	Antigens, Surface -- metabolism
	Aged
	Prospective Studies
	Neoplasm Metastasis
	Adult
	Gallium Radioisotopes
	Gallium Isotopes
	Edetic Acid -- analogs & derivatives
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:1619-7070
	info:doi/10.1007/s00259-025-07667-4
	info:pii/10.1007/s00259-025-07667-4
	info:scp/105023052829
	info:pmid/41309999